{"id":"W2464620827","doi":"10.1200/jco.2016.66.9861","title":"Nivolumab in Combination With Platinum‐Based Doublet Chemotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":447,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Nivolumab; Medicine; Pemetrexed; Carboplatin; Tolerability; Gemcitabine; Lung cancer; Oncology; Internal medicine; Cisplatin; Chemotherapy; Paclitaxel; Adverse effect; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003735103,0.0003528696,0.0007065231,0.0002554856,0.0002418136,0.0003429158,0.0003916529,0.0002379704,0.000746002],"category_scores_gemma":[0.0005890712,0.000148523,0.0003273601,0.0001674085,0.0001491471,0.0001703303,0.0001795855,0.0006591927,0.000229045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005820442,"about_ca_system_score_gemma":0.0004408745,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005954196,"about_ca_topic_score_gemma":0.003042812,"domain_scores_codex":[0.9998411,0.00006046342,0.0000167391,0.00002465526,0.00003272493,0.00002433597],"domain_scores_gemma":[0.9998713,0.00002799509,0.00003641167,0.00001241038,0.00001274653,0.00003916257],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.04501053,0.008349243,0.04074139,0.001537156,0.001755334,0.001034953,0.0004406452,0.008450686,0.1661494,0.0002337115,0.004692498,0.7216045],"study_design_scores_gemma":[0.06560526,0.2716478,0.3267575,0.0008534738,0.004339408,0.01299326,0.0004749767,0.03587659,0.2007533,0.0007136755,0.07979957,0.00018518],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9916162,0.006437737,0.0003872097,0.0001823892,0.0000975656,0.0001898642,0.00006642834,0.00005680475,0.0009658065],"genre_scores_gemma":[0.9970589,0.001400469,0.0007172663,0.0000968534,0.00004883857,0.00005930633,0.0001215762,0.00000699167,0.0004899382],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000746002,"threshold_uncertainty_score":0.004222989,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06176889032220338,"score_gpt":0.424635470981647,"score_spread":0.3628665806594436,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}